Researchers sought to determine the effects of high body mass index and low physical activity levels on incidence of subsequent neoplasms in survivors of childhood cancer.

Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

At AAPA 2025, researchers present the results of a PA-led quality improvement initiative for patients with head and neck cancer.

The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS- ...

Clinically relevant but not statistically significant improvement seen in anxiety and fatigue versus usual services.

Researchers assess the ability of the Risk Estimation of Tumor REcurrence After Transplant score to predict recurrence of hepatocellular carcinoma in patients who underwent liver transplants as a ...

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as patients who require ...

Most patients experienced at least 10 symptoms and at least one aspect of emotional impact, such as worry, depression, or anxiety.

Significantly longer progression-free and overall survival seen in patients with BRAF V600E mutations.

Researchers studied the relationship between lymphovascular invasion and adverse outcomes in patients with cutaneous squamous cell carcinoma.

The Food and Drug Administration (FDA) has approved Zusduri (mitomycin intravesical solution) for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (NMIBC).

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.